Jamie Young
Impact in
-
- Bone health and osteoporosis research
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
- Cancer Genomics and Diagnostics
Papers in
-
- Carcinogens and Genotoxicity Assessment 8
-
- DNA Repair Mechanisms 3
- Co-authors
- Paul C. Francis (3 shared papers)Gerald G. Long (3 shared papers)John L. Vahle (2 shared papers)Masahiko Sato (1 shared paper)Young Linda (1 shared paper)James B. Nold (1 shared paper)Michael S. Westmore (1 shared paper)Jeffery A. Engelhardt (1 shared paper)
- Journals
- Mutation Research/Genetic Toxicology and Environmental Mutagenesis (7 papers)Toxicologic Pathology (7 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)Nature Genetics (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Jamie Young
28 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Orthopedics and Sports Medicine 268
- Cancer Research 421
- Oncology 727
- Chemical Health and Safety 9
- Pulmonary and Respiratory Medicine 414
Countries citing papers authored by Jamie Young
This map shows the geographic impact of Jamie Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamie Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamie Young more than expected).
Fields of papers citing papers by Jamie Young
This network shows the impact of papers produced by Jamie Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamie Young. The network helps show where Jamie Young may publish in the future.
Co-authors
The 25 scholars most cited alongside Jamie Young, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 497 | |
| 2 | Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine Hit paper breakdown → | 2014 | 446 |
| 3 | 2011 | 160 | |
| 4 | 2020 | 127 | |
| 5 | 2012 | 59 | |
| 6 | 2020 | 52 | |
| 7 | 2014 | 43 | |
| 8 | 2001 | 29 | |
| 9 | 2010 | 26 | |
| 10 | 2001 | 19 | |
| 11 | 2010 | 18 | |
| 12 | 2021 | 14 | |
| 13 | 2011 | 14 | |
| 14 | 2010 | 12 | |
| 15 | 2019 | 12 | |
| 16 | 2007 | 9 | |
| 17 | 2011 | 8 | |
| 18 | 2010 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2020 | 3 |
About Jamie Young
Jamie Young is a scholar working on Cancer Research, Molecular Biology, Small Animals, Immunology and Oncology, having authored 32 papers that have together received 1.6k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (8 papers), Animal testing and alternatives (7 papers), Immunotoxicology and immune responses (5 papers), Effects and risks of endocrine disrupting chemicals (4 papers), DNA Repair Mechanisms (3 papers), Cancer Treatment and Pharmacology (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (268 citations), Cancer Research (421 citations), Oncology (727 citations), Chemical Health and Safety (9 citations) and Pulmonary and Respiratory Medicine (414 citations). Jamie Young has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Paul C. Francis, Gerald G. Long, John L. Vahle, Masahiko Sato, Young Linda, James B. Nold, Michael S. Westmore, Jeffery A. Engelhardt, David Kirkland and Paul Fowler. Their work appears in journals such as Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Toxicologic Pathology, Cancer Research, Molecular Cancer Therapeutics and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.